9-137107421-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016219.5(MAN1B1):c.1738C>G(p.Pro580Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P580L) has been classified as Uncertain significance.
Frequency
Consequence
NM_016219.5 missense
Scores
Clinical Significance
Conservation
Publications
- MAN1B1-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Rafiq syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAN1B1 | NM_016219.5 | c.1738C>G | p.Pro580Ala | missense_variant | Exon 11 of 13 | ENST00000371589.9 | NP_057303.2 | |
| MAN1B1 | XM_006716945.5 | c.1738C>G | p.Pro580Ala | missense_variant | Exon 11 of 12 | XP_006717008.1 | ||
| MAN1B1 | NR_045720.2 | n.1728C>G | non_coding_transcript_exon_variant | Exon 11 of 13 | ||||
| MAN1B1 | NR_045721.2 | n.1884C>G | non_coding_transcript_exon_variant | Exon 12 of 14 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152216Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251206 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461104Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726874 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152334Hom.: 0 Cov.: 34 AF XY: 0.000107 AC XY: 8AN XY: 74480 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Rafiq syndrome Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 580 of the MAN1B1 protein (p.Pro580Ala). This variant is present in population databases (rs200860565, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with MAN1B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 435807). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1738C>G (p.P580A) alteration is located in exon 11 (coding exon 11) of the MAN1B1 gene. This alteration results from a C to G substitution at nucleotide position 1738, causing the proline (P) at amino acid position 580 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at